Palisade Bio (STU:7NS0) Preferred Dividends : €0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Palisade Bio Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Palisade Bio's preferred dividends for the three months ended in Mar. 2024 was €0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Mar. 2024 was €0.00 Mil.

Palisade Bio Preferred Dividends Historical Data

The historical data trend for Palisade Bio's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palisade Bio Preferred Dividends Chart

Palisade Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Preferred Dividends

Palisade Bio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Preferred Dividends	Get a 7-Day Free Trial											-	-	-	-	-

Palisade Bio Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Palisade Bio (STU:7NS0) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Palisade Bio (STU:7NS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palisade Bio Inc (STU:7NS0) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

PALI:USA 7NS:Germany

Address

5800 Armada Drive, Suite 2A, Carlsbad, CA, USA, 92008

Website

https://www.palisadebio.com

Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Palisade Bio (STU:7NS0) Headlines

No Headlines